Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Monika Rau

Impact of Genetic SLC28 Transporter and ITPA Variants on Ribavirin Serum Level, Hemoglobin Drop and Therapeutic Response in Patients With HCV Infection

Journal of Hepatology

Hepatology

2013

English

Related publications

Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction

English

A Study of the Impact of Treatment Response to Direct Acting Antivirals on Serum Lipid Profile in Egyptian Patients With Chronic HCV Infection

The Medical Journal of Cairo University

2019

English

Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics

English

Role of Dendritic Cells in Chronic HCV Infection and Its Correlation With Interferon and Ribavirin Treatment Outcomes

International Journal of Science and Research (IJSR)

2016

English

Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin

Alimentary Pharmacology and Therapeutics

English

CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes

English

Drug Transporter Genetic Variants Are Not Associated With TDF-Related Renal Dysfunction in Patients With HIV-1 Infection: A Pharmacogenetic Study

PLoS ONE

Multidisciplinary

2015

English

Real-World Experience With Ombitasvir/Paritaprevir Boosted With Ritonavir and Possibly Combined With Dasabuvir and Ribavirin in HCV Infection

Clinical and Experimental Hepatology

Hepatology

2016

English

Estimation of Serum Leptin Level in Egyptian Patients With Chronic HCV After Antiviral Treatment

Journal of Gastroenterology and Hepatology Research

Hepatology

Gastroenterology

2015

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Monika Rau

Impact of Genetic SLC28 Transporter and ITPA Variants on Ribavirin Serum Level, Hemoglobin Drop and Therapeutic Response in Patients With HCV Infection

Related publications

Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction

A Study of the Impact of Treatment Response to Direct Acting Antivirals on Serum Lipid Profile in Egyptian Patients With Chronic HCV Infection

Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics

Role of Dendritic Cells in Chronic HCV Infection and Its Correlation With Interferon and Ribavirin Treatment Outcomes

Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin

CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes

Drug Transporter Genetic Variants Are Not Associated With TDF-Related Renal Dysfunction in Patients With HIV-1 Infection: A Pharmacogenetic Study

Real-World Experience With Ombitasvir/Paritaprevir Boosted With Ritonavir and Possibly Combined With Dasabuvir and Ribavirin in HCV Infection

Estimation of Serum Leptin Level in Egyptian Patients With Chronic HCV After Antiviral Treatment